TLR4-mediated release of heparin-binding protein in human airways: a co-stimulatory role for IL-26

Bacterial infection causes accumulation of neutrophils that release antimicrobial proteins including heparin-binding protein (HBP). In human airways, this neutrophil accumulation can be re-capitulated via intrabronchial exposure to lipopolysaccharide (LPS), a Toll-like receptor 4 (TLR4) agonist, tha...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1178135
Main Authors Paulsson, Magnus, Cardenas, Eduardo I, Che, Karlhans F, Brundin, Bettina, Smith, Margaretha, Qvarfordt, Ingemar, Lindén, Anders
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bacterial infection causes accumulation of neutrophils that release antimicrobial proteins including heparin-binding protein (HBP). In human airways, this neutrophil accumulation can be re-capitulated via intrabronchial exposure to lipopolysaccharide (LPS), a Toll-like receptor 4 (TLR4) agonist, that also causes a local increase in the neutrophil-mobilizing cytokine IL-26. Although LPS is considered a weak stimulus for HBP release , its effect on HBP release in human airways has not been characterized. We determined whether intrabronchial exposure to LPS causes concomitant release of HBP and IL-26 in human airways, and whether IL-26 can enhance LPS-induced release of HBP in isolated human neutrophils. We found that the concentration of HBP was markedly increased in bronchoalveolar lavage (BAL) fluid 12, 24, and 48 hours after LPS exposure, and that it displayed a strong and positive correlation with that of IL-26. Moreover, the concentration of HBP in conditioned media from isolated neutrophils was enhanced only after co-stimulation with LPS and IL-26. Taken together, our findings indicate that TLR4 stimulation causes concomitant release of HBP and IL-26 in human airways, and that IL-26 may constitute a required co-stimulant for HBP release in neutrophils, thus enabling the concerted action of HBP and IL-26 in local host defense.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors have contributed equally to this work and share first authorship
Edited by: Susanna Brighenti, Karolinska Institutet (KI), Sweden
Reviewed by: Anne Kasus-Jacobi, University of Oklahoma Health Sciences Center, United States; Yves Delneste, Institut National de la Santé et de la Recherche Médicale (INSERM), France
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1178135